Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765412 · ClinicalTrials.gov registry record
PrOVE QUERI Project #1
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 17,033
- Enrollment target
NCT02765412: Completed study, sponsored by VA Office of Research and Development.
NCT02765412 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 17,033 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765412 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 17,033 participants
- Enrollment target
Study Summary
The overall goal of this project is to test two strategies for implementing a shared decision making tool to be used by providers while talking to patients about lung cancer screening. Eight participating sites will be randomized to compare standard implementation with intensive implementation. Additionally, the investigators will determine the factors that were most important for successful implementation of the shared decision making tool. Finally, the investigators will survey patients to evaluate the effects of Decision Precision on patient's knowledge of the risks and benefits of lung cancer screening, the quality of their decision making, and their satisfaction with care.
Primary Outcome
First, we estimated screening's net benefit for an individual based on their baseline lung cancer risk, as estimated using the Bach et. al. annual lung cancer incidence model. Patients are considered "high benefit" if their annual lung cancer risk is between 0.3%-1.3%. Patients outside this range are considered "preference sensitive". We fit a multilevel logistic regression model where receipt of screening is the outcome. Precision decision making is reflected in the association between baseline
Interventions
- OTHER Academic Detailing
- OTHER Audit and Feedback
- OTHER LEAP
- OTHER Webinar, Promotion, and Tool Access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,033 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2020-05-31 |
What the finished NCT02765412 record still lists
NCT02765412 is an observational study that tracks outcomes without assigning an intervention. Its 17,033 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Academic Detailing is the first listed.
NCT02765412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02765412 about?
NCT02765412 is a clinical study titled "PrOVE QUERI Project #1". The overall goal of this project is to test two strategies for implementing a shared decision making tool to be used by providers while talking to patients about lung cancer screening. Eight participating sites will be randomized to compare standard implementation with intensive implementation. Addi...
What is the current status of trial NCT02765412?
This trial is currently completed. The enrollment target is 17,033 participants. The study started on 2016-11-15. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT02765412?
The interventions under investigation include: Academic Detailing (OTHER), Audit and Feedback (OTHER), LEAP (OTHER), Webinar, Promotion, and Tool Access (OTHER).
Who is sponsoring clinical trial NCT02765412?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI